↓ Skip to main content

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia.

Overview of attention for article published in Journal of Clinical Psychopharmacology, November 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 3,822)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
8 news outlets
twitter
2 X users

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia.
Published in
Journal of Clinical Psychopharmacology, November 2019
DOI 10.1097/jcp.0000000000001111
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 7 13%
Student > Master 6 12%
Other 5 10%
Student > Ph. D. Student 4 8%
Researcher 4 8%
Other 4 8%
Unknown 22 42%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 11 21%
Nursing and Health Professions 4 8%
Psychology 3 6%
Immunology and Microbiology 2 4%
Sports and Recreations 2 4%
Other 7 13%
Unknown 23 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 60. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2020.
All research outputs
#898,339
of 34,411,289 outputs
Outputs from Journal of Clinical Psychopharmacology
#47
of 3,822 outputs
Outputs of similar age
#15,554
of 414,988 outputs
Outputs of similar age from Journal of Clinical Psychopharmacology
#1
of 58 outputs
Altmetric has tracked 34,411,289 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,822 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 414,988 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.